CDH1 and Miyoshi myopathy: In addition to the significant difference in OS (25.8 vs. 51.5 months;p=0.0443), it is noteworthy that negative E-cadherin expression in MM patients in this study was associated with lower serum albumin and hemoglobin levels, suggesting that the loss of this molecule is either a deteriorating factor or a marker for disease severity and shorter OS.